Immunovaccine Inc. announced that it has appointed Joseph Sullivan to the newly created role of Senior Vice President, Business Development, effective January 22, 2018. Mr. Sullivan brings over 25 years of global pharmaceutical and vaccine experience with Merck & Co Inc. to his new position at Immunovaccine. At Immunovaccine, he will be responsible for providing strategic and operational leadership for the Company's business development efforts. This includes expanding late stage candidate development and preparation for commercialization, as well as forging strategic commercial partnerships to support further advancement of the company's clinical assets and platform. Most recently, he served as the Executive Director, Partner Strategy and Implementation Lead, at Merck & Co Inc.